Bipolar depression
Drug research and approvals for bipolar depression: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 114 studies of bipolar depression are recruiting on ClinicalTrials.gov, and Health Canada has authorized 11 drug trials for it since 2013.
- Recruiting worldwide: 114
- Trials authorized in Canada: 11
- FDA orphan approvals: 0
- EU medicines: 0
Newest posted first, of 114 recruiting on ClinicalTrials.gov ↗
- Preventing Mood Disorders in High-risk Offspring: Protocol for the Randomized Controlled Trial of the MARIO Online…NCT07938593 · Not applicable · Erasmus Medical Center · starts Nov 29, 2022
- Health Assessment in People With Severe Mental IllnessNCT07931456 · Not reported · University of the Basque Country (UPV/EHU) · starts Apr 17, 2026
- Affective Cognitive Training in Mood Disorders and High-risk RelativesNCT07920302 · Not applicable · Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · starts Nov 17, 2025
- A Prospective Study of Anxiety, Depression, and Bipolar Disorder in PeopleNCT07903246 · Not reported · Second Affiliated Hospital, Zhejiang University, School of Medicine · starts Sep 15, 2026
- French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic…NCT07881016 · Not applicable · Fondation FondaMental · starts Jun 11, 2026
- Safety and Feasibility of DBS for Bipolar DepressionNCT07745374 · Not applicable · Icahn School of Medicine at Mount Sinai · starts Sep 21, 2026
- Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to TreatmentNCT07741981 · Not applicable · Centre Hospitalier St Anne · starts Aug 20, 2026
- EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECTNCT07740694 · Not reported · Istanbul University - Cerrahpasa · starts Dec 1, 2025
- Transition Care for FEPNCT07713849 · Not reported · University of Chicago · starts May 6, 2026
The 10 newest of 11; search them all in Canada trials
| Oct 18, 2024 | The candesartan adjunctive bipolar depression trial - cadet: a double-blind, randomised, placebo-controlled trialCandesartan | Ottawa Hospital Research Institute | Pending |
| Mar 8, 2023 | Cannabidiol adjunctive therapy for acute bipolar depression: a randomized double-blind, placebo controlled trialCannabidiol (PROZ-001) | Dr. Lakshmi Yatham | Ongoing |
| Dec 12, 2022 | Feasibility of inhaled nitrous oxide (N2O) versus placebo in treatment-resistant bipolar disorderNitrous oxide | St Michaels Hospital | Pending |
| Sep 8, 2022 | A randomized, stratified, double-blind, placebo-controlled study to investigate the efficacy, safety and tolerability of JNJ-55308942 in bipolar depressionJNJ-55308942 | Johnson & Johnson | Closed |
| Apr 22, 2022 | Neurobiological effects of psilocybin in treatment resistant bipolar depression: an emotional-processing fmri pilot studyPsilocybin | Dr. Joshua D. Rosenblat | Ongoing |
| Nov 12, 2021 | Maintenance ketamine infusions for treatment-resistant bipolar depression: an open-label extension trialKetamine | University Health Network | Ongoing |
| May 13, 2021 | Neural correlates of anti-suicidal response to ketamine in treatment resistant bipolar depression (deepp-study). pilot projectKetamine | Centre for Addiction and Mental Health | Ongoing |
| Oct 15, 2020 | Low-dose adjunctive brexpiprazole in the treatment of bipolar i and ii depression: an open-label studyBrexpiprazole | Douglas Mental Health University Institute | Ongoing |
| May 14, 2020 | Pentoxifylline for bipolar depression: a proof-of-concept feasibility studyPentoxifylline | Dr. Joshua D. Rosenblat | Pending |
| Jun 13, 2014 | A mulitsite, randomized, double-blind, placebo-controlled 12-week study evaluating the efficacy, safety, and tolerability of adjunctive infliximab for the…Remicade (infliximab) | University Health Network | Pending |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA